Ocular Hypotension

Download PDF

Recent Publications on Ocular Hypotension:
Infusion aspiration mismatch during 25-gauge vitrectomy with conversion to 20-gauge vitrector. We report intraoperative hypotony throughout the 25G vitrectomy procedure...	11th July, 2008	Eye Treatment Centre, Whipps Cross University Hospital, London, UK.	Ann Ophthalmol (Skokie). 2008 Spring;40(1):51-2.
E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial. PURPOSE: To test the expanded polytetrafluoroethylene (ePTFE) as a new...	9th July, 2008	Department of Clinical Neuroscience, Section of Ophthalmology, University	Acta Ophthalmol. 2008 May;86(3):314-21. Epub 2007 Nov 8. DOI Direct Link
Rebound tonometry in conscious, conditioned mice avoids the acute and profound effects of anesthesia on intraocular pressure. AIMS: The aims of this study were to evaluate the accuracy, repeatability,...	25th June, 2008	Department of Ophthalmology and Visual Sciences, University of Nebraska	J Ocul Pharmacol Ther. 2008 Apr;24(2):175-85. DOI Direct Link
Early postoperative hypotony after 25-gauge sutureless vitrectomy with straight incisions. PURPOSE: To evaluate the rate, duration, and associated complications of...	21st May, 2008	Beyoglu Eye Research and Training Hospital, Istanbul, Turkey.	Retina. 2008 Apr;28(4):545-52. DOI Direct Link
Densiron intraocular tamponade: a case series. PURPOSE: To report on the use of Densiron (heavy silicone oil), a new...	16th May, 2008	The Eye Hospital, Launceston, Tasmania, Australia.	Clin Experiment Ophthalmol. 2008 Apr;36(3):261-4. DOI Direct Link
→View more research publications.

Ocular Hypotension Clinical Trials:
Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)	Proliferative Vitreoretinopathy

Ocular Hypotension Patents:
US Patent No.	Title
5114971	Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
5552434	7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these compounds
5574066	Intraocular pressure reducing 15-acyl prostaglandins
5578618	Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
5625083	Dinitroglycerol esters of unsaturated fatty acids and prostaglandins
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Ocular Hypotension scientists - we have details of around 62 individuals working on Ocular Hypotension .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.